01 1Synbias Pharma AG
01 1VALRUBICIN USP
01 1Switzerland
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2013-12-04
Pay. Date : 2013-04-15
DMF Number : 26918
Submission : 2013-02-26
Status : Active
Type : II
20
Synbias Pharma Ag, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is VALRUBICIN USP, with a corresponding US DMF Number 26918.
Remarkably, this DMF maintains an Active status since its submission on February 26, 2013, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 04, 2013, and payment made on April 15, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II
